Asia Healthcare Tour Takeaways We recently visited Hengrui during our Grand Asia Healthcare Tour during Sep 17-26. Below are key takeaways with full transcripts attached. Deep Pipeline Across Core Therapeutic Areas with Differentiated Modalities China (PRC) | Pharmaceuticals Global Value Maximization Through Flexible Partnering Models Hengrui's ex-China strategy focuses on unlocking full asset value through a combination of out-licensing and equity-linked NewCo structures. Recent transactions, such as the G ...